nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CELA1—ventral pancreatic duct—bile duct cancer	0.658	0.684	CbGeAlD
Telaprevir—ORM1—bile—bile duct cancer	0.0604	0.0628	CbGeAlD
Telaprevir—CELA1—pancreas—bile duct cancer	0.044	0.0458	CbGeAlD
Telaprevir—CTSK—gall bladder—bile duct cancer	0.032	0.0333	CbGeAlD
Telaprevir—CTSS—gall bladder—bile duct cancer	0.0281	0.0292	CbGeAlD
Telaprevir—ORM1—gall bladder—bile duct cancer	0.0168	0.0174	CbGeAlD
Telaprevir—CTSK—pancreas—bile duct cancer	0.0148	0.0154	CbGeAlD
Telaprevir—ALB—gall bladder—bile duct cancer	0.0147	0.0153	CbGeAlD
Telaprevir—CMA1—liver—bile duct cancer	0.0146	0.0152	CbGeAlD
Telaprevir—CTSS—pancreas—bile duct cancer	0.0129	0.0135	CbGeAlD
Telaprevir—CMA1—lymph node—bile duct cancer	0.0112	0.0116	CbGeAlD
Telaprevir—CTSK—liver—bile duct cancer	0.00939	0.00977	CbGeAlD
Telaprevir—CTSS—liver—bile duct cancer	0.00823	0.00856	CbGeAlD
Telaprevir—CTSK—lymph node—bile duct cancer	0.0072	0.00749	CbGeAlD
Telaprevir—CTSS—lymph node—bile duct cancer	0.00631	0.00656	CbGeAlD
Telaprevir—ORM1—liver—bile duct cancer	0.00491	0.00511	CbGeAlD
Telaprevir—ALB—liver—bile duct cancer	0.00431	0.00448	CbGeAlD
Telaprevir—ORM1—lymph node—bile duct cancer	0.00377	0.00392	CbGeAlD
Telaprevir—ALB—lymph node—bile duct cancer	0.0033	0.00344	CbGeAlD
Telaprevir—CMA1—ACE Inhibitor Pathway—TGFB1—bile duct cancer	0.00232	0.0601	CbGpPWpGaD
Telaprevir—ABCB1—pancreas—bile duct cancer	0.00228	0.00237	CbGeAlD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP2—bile duct cancer	0.00226	0.0585	CbGpPWpGaD
Telaprevir—CYP3A4—liver—bile duct cancer	0.00205	0.00213	CbGeAlD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP2—bile duct cancer	0.00201	0.0521	CbGpPWpGaD
Telaprevir—CTSK—Collagen degradation—MMP2—bile duct cancer	0.00176	0.0454	CbGpPWpGaD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—bile duct cancer	0.0017	0.044	CbGpPWpGaD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—bile duct cancer	0.00151	0.0392	CbGpPWpGaD
Telaprevir—ABCB1—liver—bile duct cancer	0.00145	0.00151	CbGeAlD
Telaprevir—CTSK—Collagen degradation—MMP9—bile duct cancer	0.00132	0.0341	CbGpPWpGaD
Telaprevir—ABCB1—lymph node—bile duct cancer	0.00111	0.00116	CbGeAlD
Telaprevir—CMA1—Extracellular matrix organization—TNC—bile duct cancer	0.00101	0.0261	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.000997	0.0258	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TNC—bile duct cancer	0.000899	0.0233	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.000889	0.023	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MUC1—bile duct cancer	0.000853	0.0221	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MUC4—bile duct cancer	0.000853	0.0221	CbGpPWpGaD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—bile duct cancer	0.000846	0.0219	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.000749	0.0194	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TNC—bile duct cancer	0.00074	0.0192	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.000732	0.0189	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.000668	0.0173	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MUC2—bile duct cancer	0.000646	0.0167	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—ERBB2—bile duct cancer	0.000605	0.0156	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—MMP9—bile duct cancer	0.000576	0.0149	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.00055	0.0142	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—MMP9—bile duct cancer	0.000519	0.0134	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—NRAS—bile duct cancer	0.00046	0.0119	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—bile duct cancer	0.000419	0.0108	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP2—bile duct cancer	0.000418	0.0108	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—KRAS—bile duct cancer	0.000396	0.0102	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—MMP2—bile duct cancer	0.000372	0.00964	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—HRAS—bile duct cancer	0.000337	0.00871	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—IL6—bile duct cancer	0.000322	0.00833	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP9—bile duct cancer	0.000314	0.00813	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP2—bile duct cancer	0.000307	0.00794	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RNF43—bile duct cancer	0.000305	0.00788	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.000287	0.00743	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—MMP9—bile duct cancer	0.00028	0.00724	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—TGFB1—bile duct cancer	0.000259	0.0067	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.00024	0.00621	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.000236	0.00612	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000231	0.00598	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TGFB1—bile duct cancer	0.000231	0.00597	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP9—bile duct cancer	0.00023	0.00596	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—HGF—bile duct cancer	0.000228	0.0059	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.000217	0.00562	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MMP2—bile duct cancer	0.000195	0.00505	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB1—bile duct cancer	0.00019	0.00492	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000179	0.00462	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HGF—bile duct cancer	0.000176	0.00456	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB2—bile duct cancer	0.000175	0.00452	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB2—bile duct cancer	0.000168	0.00434	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HGF—bile duct cancer	0.000145	0.00376	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB2—bile duct cancer	0.000144	0.00372	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFBR2—bile duct cancer	0.000139	0.0036	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB2—bile duct cancer	0.000138	0.00357	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GNAS—bile duct cancer	0.000134	0.00347	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—bile duct cancer	0.000133	0.00344	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SMAD4—bile duct cancer	0.000132	0.00341	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—bile duct cancer	0.000128	0.0033	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—bile duct cancer	0.000121	0.00313	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00012	0.0031	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000119	0.00308	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—bile duct cancer	0.000116	0.00301	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—bile duct cancer	0.000114	0.00296	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—bile duct cancer	0.00011	0.00284	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—bile duct cancer	0.000109	0.00283	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—bile duct cancer	0.000105	0.00272	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FAR2—bile duct cancer	0.000103	0.00267	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000103	0.00265	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—bile duct cancer	0.000102	0.00263	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000101	0.00262	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	0.0001	0.0026	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—bile duct cancer	9.96e-05	0.00258	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—bile duct cancer	9.72e-05	0.00251	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	9.71e-05	0.00251	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—bile duct cancer	9.57e-05	0.00248	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—bile duct cancer	9.41e-05	0.00244	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—bile duct cancer	9.33e-05	0.00241	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6—bile duct cancer	9.3e-05	0.00241	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB1—bile duct cancer	9.29e-05	0.0024	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—bile duct cancer	9.04e-05	0.00234	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FAR2—bile duct cancer	9.02e-05	0.00234	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—bile duct cancer	8.92e-05	0.00231	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	8.85e-05	0.00229	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—bile duct cancer	8.37e-05	0.00217	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	8.22e-05	0.00213	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL6—bile duct cancer	8.16e-05	0.00211	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—bile duct cancer	8e-05	0.00207	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—bile duct cancer	7.74e-05	0.002	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—bile duct cancer	7.68e-05	0.00199	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—bile duct cancer	7.66e-05	0.00198	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—bile duct cancer	7.38e-05	0.00191	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—bile duct cancer	7.05e-05	0.00182	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—bile duct cancer	6.66e-05	0.00172	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	6.48e-05	0.00168	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—bile duct cancer	6.37e-05	0.00165	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—bile duct cancer	6.33e-05	0.00164	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	6.09e-05	0.00158	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—bile duct cancer	5.8e-05	0.0015	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	5.74e-05	0.00148	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—bile duct cancer	5.66e-05	0.00146	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—bile duct cancer	5.61e-05	0.00145	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	5.61e-05	0.00145	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FAR2—bile duct cancer	5.56e-05	0.00144	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—bile duct cancer	5.48e-05	0.00142	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GNAS—bile duct cancer	5.47e-05	0.00142	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—bile duct cancer	5.42e-05	0.0014	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	5.34e-05	0.00138	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFB1—bile duct cancer	5.21e-05	0.00135	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HGF—bile duct cancer	5.21e-05	0.00135	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—bile duct cancer	5.11e-05	0.00132	CbGpPWpGaD
Telaprevir—ALB—Metabolism—IDH2—bile duct cancer	5.03e-05	0.0013	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—bile duct cancer	4.83e-05	0.00125	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	4.73e-05	0.00123	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—bile duct cancer	4.66e-05	0.00121	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—bile duct cancer	4.46e-05	0.00115	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—IDH2—bile duct cancer	4.41e-05	0.00114	CbGpPWpGaD
Telaprevir—ALB—Metabolism—IDH1—bile duct cancer	4.33e-05	0.00112	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—bile duct cancer	4.29e-05	0.00111	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	4.15e-05	0.00107	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	4.12e-05	0.00107	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—bile duct cancer	4.1e-05	0.00106	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	4.06e-05	0.00105	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—bile duct cancer	3.99e-05	0.00103	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	3.98e-05	0.00103	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—bile duct cancer	3.93e-05	0.00102	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—IDH1—bile duct cancer	3.79e-05	0.000981	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.76e-05	0.000972	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.34e-05	0.000864	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC5A5—bile duct cancer	2.85e-05	0.000738	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—IDH2—bile duct cancer	2.72e-05	0.000703	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.67e-05	0.000692	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A5—bile duct cancer	2.5e-05	0.000647	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—IDH1—bile duct cancer	2.33e-05	0.000604	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—bile duct cancer	2.29e-05	0.000591	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNAS—bile duct cancer	2.22e-05	0.000574	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—bile duct cancer	2.12e-05	0.000549	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—bile duct cancer	1.97e-05	0.000509	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNAS—bile duct cancer	1.94e-05	0.000503	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—bile duct cancer	1.75e-05	0.000452	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—bile duct cancer	1.67e-05	0.000433	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A5—bile duct cancer	1.54e-05	0.000399	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNAS—bile duct cancer	1.2e-05	0.00031	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—bile duct cancer	1.19e-05	0.000308	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—bile duct cancer	1.04e-05	0.00027	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—bile duct cancer	6.43e-06	0.000166	CbGpPWpGaD
